Disclaimer

The alfapump® system is currently not approved in Canada for commercial use. DSR® therapy is still in development and is currently not approved in the United States or Canada. Any statements regarding safety and efficacy arise from ongoing pre-clinical and clinical investigations which have yet to be completed. Sequana Medical makes no claims of safety or effectiveness of the DSR® therapy in the U.S. or Canada. There is no link between the DSR® therapy and ongoing investigations with the alfapump® system in Europe, the United States or Canada.

Contacts
Contacts

Social Life

Patients suffering from ascites report feelings of isolation and depression because of their immobility and limitations in their daily activities. It also entails a huge burden for their family members because of the frequent hospital visits for paracentesis and the feeling of being housebound and constant worrying when not around.

Although the alfapump® does not treat the underlying condition, patients who have been implanted with an alfapump® very often experience a significant improvement to their social life usually associated to their overall quality of life.

Many patients have been able to resume some of the light activities they enjoyed before suffering from ascites, such as swimming or taking a short walk. And many patients have reported an increase in appetite, enabling them to improve their nutrition, which is often critical in helping to manage their underlying disease.